BT
Bectas Therapeutics, Inc.
SEC filingBiotechnology · Houston, TX
Amount raised$5.6Msold at filing
Total offering$10M$4.5M still open
Investors in the raise13count reported to the SEC
FiledOct 8, 2025first sale Oct 21, 2022
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jon A. BrilliantExecutive Officer
Ronan O'HaganExecutive Officer, Director
Lynda ChinDirector
Executive officers, directors and promoters as listed on the Form D.